Chong‐De Lu
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
- Hepatology 12
- Hepatocellular Carcinoma Treatment and Prognosis 11
- Liver Disease and Transplantation 3
- Surgery 9
- Cholangiocarcinoma and Gallbladder Cancer Studies 7
- Co-authors
- Xiaohui Fu (4 shared papers)Shuqun Cheng (9 shared papers)Wei‐Xing Guo (6 shared papers)Xiaoping Yao (3 shared papers)Wan Yee Lau (8 shared papers)Jie Xue (4 shared papers)Dong Xie (2 shared papers)Hongwei Zhang (1 shared paper)
- Journals
- Nature Medicine (1 paper)International Journal of Surgery (1 paper)Journal of Hepatology (1 paper)BioScience Trends (1 paper)European Journal of Gastroenterology & Hepatology (1 paper)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Chong‐De Lu
13 papers receiving 372 citations
Hit Papers
Peers
Comparison fields: 5 of 51
- Hepatology 155
- Cancer Research 141
- Oncology 101
- Surgery 118
- Epidemiology 74
Countries citing papers authored by Chong‐De Lu
This map shows the geographic impact of Chong‐De Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chong‐De Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chong‐De Lu more than expected).
Fields of papers citing papers by Chong‐De Lu
This network shows the impact of papers produced by Chong‐De Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chong‐De Lu. The network helps show where Chong‐De Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Chong‐De Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 132 | |
| 2 | Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial Hit paper breakdown → | 2024 | 64 |
| 3 | 2013 | 58 | |
| 4 | 2013 | 43 | |
| 5 | 2010 | 20 | |
| 6 | 2015 | 16 | |
| 7 | 2014 | 15 | |
| 8 | 2019 | 9 | |
| 9 | 2023 | 8 | |
| 10 | 2023 | 5 | |
| 11 | 2020 | 3 | |
| 12 | 2024 | 2 | |
| 13 | 2009 | 1 | |
| 14 | 2024 | 0 | |
| 15 | 2025 | 0 | |
| 16 | 2023 | 0 |
About Chong‐De Lu
Chong‐De Lu is a scholar working on Hepatology, Surgery, Epidemiology, Pathology and Forensic Medicine and Cancer Research, having authored 16 papers that have together received 376 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (11 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers), Cancer Mechanisms and Therapy (3 papers), Liver Disease Diagnosis and Treatment (3 papers), Liver Disease and Transplantation (3 papers), MicroRNA in disease regulation (2 papers), Cancer, Lipids, and Metabolism (2 papers) and Hepatitis B Virus Studies (2 papers). The work is most often cited by research in Hepatology (155 citations), Cancer Research (141 citations), Oncology (101 citations), Surgery (118 citations) and Epidemiology (74 citations). Chong‐De Lu has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Xiaohui Fu, Shuqun Cheng, Wei‐Xing Guo, Xiaoping Yao, Wan Yee Lau, Jie Xue, Dong Xie, Hongwei Zhang, Hui Dong and Jiang‐Sha Zhao. Their work appears in journals such as Nature Medicine, International Journal of Surgery, Journal of Hepatology, BioScience Trends and European Journal of Gastroenterology & Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.